Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
101 participants
INTERVENTIONAL
2021-06-23
2025-02-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In this context, RECODE study has a twofold objective:
* To determine whether the positive emotions recognition remains preserved by combining behavioural and neurophysiological measures (electrodermal activity).
* To study this disorder's etiology through a comparison between a multiple sclerosis patient group and a control group (matched in sex, age, and education's level).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
1 control group composed of volunteers matched in gender, age, and education's level with the experimental group
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental group : patients with multiple sclerosis
The experimental group will be constituted of patients with multiple sclerosis.
Carrying out a tests and questionnaires battery
The attendees will carry out different questionnaires and tests to evaluate their potential cognitive disorders
Control group : volunteers
The control group will be constituted of healthy volunteers with the same characteristics concerning age, sex, education's level as experimental group's patients
Carrying out a tests and questionnaires battery
The attendees will carry out different questionnaires and tests to evaluate their potential cognitive disorders
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Carrying out a tests and questionnaires battery
The attendees will carry out different questionnaires and tests to evaluate their potential cognitive disorders
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Understand and able to express themselves in French.
* EXPERIMENTAL GROUP :
* Relapsing-remitting form (RRMS)
* With an EDSS \< 4 (Expanded Disability Status Scale)
* No significant motor, cerebellar or somatosensory disorders of the upper limbs or visual disorders (EDSS specific parameter \<2)
* No flare-up in the last 6 weeks
* No corticosteroids taken in the last 4 weeks
* CONTROL GROUP :
* Lack of global cognitive deterioration (according to Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) standards).
* Gender, age and education level matching to the multiple sclerosis patients
* Understanding and signing the informed consent and information letter regarding participation in the study.
* Benefiting from health insurance coverage.
Exclusion Criteria
* People with sensory disorders (visual and auditory) that interfere with the performance of neuropsychological tests;
* Treatment with psychotropic drugs (except benzodiazepines and hypnotics).
* Refusal to participate after clear and fair information about the study.
* Major persons under guardianship, under judicial protection, persons deprived of liberty.
* Pregnant or breastfeeding women
18 Years
55 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Lille Catholic University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bruno Lenne
Role: PRINCIPAL_INVESTIGATOR
Hôpital Saint Vincent de Paul, Lille
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpital Saint-Vincent de Paul
Lille, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RC-P00107
Identifier Type: -
Identifier Source: org_study_id